Nicolas Le Novère

1992-1999 Institut Pasteur, Paris, Paris, France 
 1999-2001 University of Cambridge, Cambridge, England, United Kingdom 
 2001-2003 Institut Pasteur, Paris, Paris, France 
 2003-2012 EMBL-European Bioinformatics Institute 
 2012- Babraham Institute, Babraham, England, United Kingdom 
"Nicolas Le Novère"
BETA: Related publications


You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Pir P, Le Novère N. (2016) Mathematical models of pluripotent stem cells: At the dawn of predictive regenerative medicine Methods in Molecular Biology. 1386: 331-350
Stanford NJ, Wolstencroft K, Golebiewski M, et al. (2015) The evolution of standards and data management practices in systems biology. Molecular Systems Biology. 11: 851
Seeliger C, Le Novère N. (2015) Enabling surface dependent diffusion in spatial simulations using Smoldyn. Bmc Research Notes. 8: 752
Quinn JY, Cox RS, Adler A, et al. (2015) SBOL Visual: A Graphical Language for Genetic Designs. Plos Biology. 13: e1002310
Hucka M, Bergmann FT, Dräger A, et al. (2015) Systems Biology Markup Language (SBML) Level 2 Version 5: Structures and Facilities for Model Definitions. Journal of Integrative Bioinformatics. 12: 271
Bergmann FT, Cooper J, Le Novère N, et al. (2015) Simulation Experiment Description Markup Language (SED-ML) Level 1 Version 2. Journal of Integrative Bioinformatics. 12: 262
Bergmann FT, Rodriguez N, Le Novère N. (2015) COMBINE Archive Specification Version 1. Journal of Integrative Bioinformatics. 12: 261
Schreiber F, Bader GD, Golebiewski M, et al. (2015) Specifications of Standards in Systems and Synthetic Biology. Journal of Integrative Bioinformatics. 12: 258
Ebrahim A, Almaas E, Bauer E, et al. (2015) Do genome-scale models need exact solvers or clearer standards? Molecular Systems Biology. 11: 831
Swat MJ, Moodie S, Wimalaratne SM, et al. (2015) Pharmacometrics Markup Language (PharmML): Opening New Perspectives for Model Exchange in Drug Development. Cpt: Pharmacometrics & Systems Pharmacology. 4: 316-9
See more...